Since we previously found that the decrease in CD34-MVD was associated with tumor invasion events (tumor enlargement and lymph node metastasis), thus explaining the favorable prognosis of patients with high CD34-MVD and the poor prognosis of those with low CD34-MVD. The gene discussed is CD34; the disease is metastatic malignant neoplasm in the lymph nodes.